- Home
- BGLC vs BMRA Comparison
BGLC vs BMRA Comparison
Compare BGLC & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- BMRA
- Stock Information
- Founded
- BGLC 2017
- BMRA 1971
- Country
- BGLC Malaysia
- BMRA United States
- Employees
- BGLC N/A
- BMRA N/A
- Industry
- BGLC Medical Specialities
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BGLC Health Care
- BMRA Health Care
- Exchange
- BGLC Nasdaq
- BMRA Nasdaq
- Market Cap
- BGLC 10.4M
- BMRA 8.2M
- IPO Year
- BGLC N/A
- BMRA N/A
- Fundamental
- Price
- BGLC $5.70
- BMRA $2.92
- Analyst Decision
- BGLC
- BMRA
- Analyst Count
- BGLC 0
- BMRA 0
- Target Price
- BGLC N/A
- BMRA N/A
- AVG Volume (30 Days)
- BGLC 176.1K
- BMRA 425.8K
- Earning Date
- BGLC 11-14-2025
- BMRA 10-14-2025
- Dividend Yield
- BGLC N/A
- BMRA N/A
- EPS Growth
- BGLC N/A
- BMRA N/A
- EPS
- BGLC N/A
- BMRA N/A
- Revenue
- BGLC $9,551,559.00
- BMRA $5,311,000.00
- Revenue This Year
- BGLC N/A
- BMRA N/A
- Revenue Next Year
- BGLC N/A
- BMRA N/A
- P/E Ratio
- BGLC N/A
- BMRA N/A
- Revenue Growth
- BGLC 4.01
- BMRA N/A
- 52 Week Low
- BGLC $2.01
- BMRA $2.08
- 52 Week High
- BGLC $15.60
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- BGLC 55.45
- BMRA 43.27
- Support Level
- BGLC $4.20
- BMRA $2.87
- Resistance Level
- BGLC $5.65
- BMRA $3.08
- Average True Range (ATR)
- BGLC 0.34
- BMRA 0.21
- MACD
- BGLC 0.01
- BMRA 0.01
- Stochastic Oscillator
- BGLC 83.33
- BMRA 54.93
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.